Back to User profile » Dr Fei-Long Tian
Papers published by Dr Fei-Long Tian:
Retraction
Sulfasalazine Inhibits Inflammation and Fibrogenesis in Pancreas via NF-κB Signaling Pathway in Rats with Oxidative Stress-Induced Pancreatic Injury [Retraction]
Wang Y, Tian F, Yan M, Fan J, Wang L, Kuang R, Li Y
Drug Design, Development and Therapy 2022, 16:2729-2730
Published Date: 18 August 2022
Corrigendum
Sulfasalazine Inhibits Inflammation and Fibrogenesis in Pancreas via NF-κB Signaling Pathway in Rats with Oxidative Stress-Induced Pancreatic Injury [Corrigendum]
Wang Y, Tian F, Yan M, Fan J, Wang L, Kuang R, Li Y
Drug Design, Development and Therapy 2021, 15:2563-2564
Published Date: 16 June 2021
Original Research
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sulfasalazine inhibits inflammation and fibrogenesis in pancreas via NF-κB signaling pathway in rats with oxidative stress-induced pancreatic injury
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/_ZT_dstfjIw/1.jpg)
Wang YR, Tian FL, Yan MX, Fan JH, Wang LY, Kuang RG, Li YQ
Drug Design, Development and Therapy 2016, 10:1743-1751
Published Date: 24 May 2016